Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30001467
Basic Information
VIS ID
TVIS30001467
Fusion event
HIV-DDI2 integration
Validated
No
Detection method
QiaQuick PCR and Sequencing
Data source
download(RID)
Sample type
Cell line
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2013
PubMed ID
23953889
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr1
Cytoband
p36.21
Reference genome
GRCh37/hg19
Start
15948365/15621870 (Hg38)
End
15948365/15621870 (Hg38)
Orient
+
Location type
Intronic
Fragile sites / regions
FRA1A
Target gene
DDI2
miRNAs that regulate target gene
hsa-mir-484
;
hsa-mir-7-5p
;
hsa-mir-1227-5p
;
hsa-mir-3151-5p
;
hsa-mir-128-2-5p
;
hsa-mir-128-1-5p
;
hsa-mir-6845-5p
;
hsa-mir-6762-5p
;
hsa-mir-770-5p
;
hsa-mir-4712-5p
;
hsa-mir-194-3p
;
hsa-mir-5000-3p
;
hsa-mir-4436a
;
hsa-mir-5586-5p
;
hsa-mir-3159
;
hsa-mir-1296-3p
;
hsa-mir-4700-3p
;
hsa-mir-137
;
hsa-mir-367-3p
;
hsa-mir-25-3p
;
hsa-mir-32-5p
;
hsa-mir-363-3p
;
hsa-mir-92a-3p
;
hsa-mir-92b-3p
;
hsa-mir-216a-3p
;
hsa-mir-128-3p
;
hsa-mir-3681-3p
;
hsa-mir-140-3p
;
hsa-mir-6083
;
hsa-mir-190a-3p
;
hsa-mir-6787-5p
;
hsa-mir-663a
;
hsa-mir-1908-5p
;
hsa-mir-299-3p
;
hsa-mir-4657
;
hsa-mir-4491
;
hsa-mir-5011-5p
;
hsa-mir-1277-5p
;
hsa-mir-5006-3p
;
hsa-mir-4446-5p
;
hsa-mir-4755-5p
;
hsa-mir-489-3p
;
hsa-mir-642a-5p
;
hsa-mir-3913-3p
;
hsa-mir-4277
;
hsa-mir-5584-3p
;
hsa-mir-27a-3p
;
hsa-mir-27b-3p
;
hsa-mir-4756-3p
;
hsa-mir-3919
;
hsa-mir-5582-5p
;
hsa-mir-3910
;
hsa-mir-3714
;
hsa-mir-551b-5p
;
hsa-mir-506-3p
;
hsa-mir-124-3p
;
hsa-mir-5089-5p
;
hsa-mir-7151-3p
;
hsa-mir-5095
;
hsa-mir-5589-5p
;
hsa-mir-4731-5p
;
hsa-mir-6506-5p
;
hsa-mir-619-5p
;
hsa-mir-150-5p
;
hsa-mir-186-3p
;
hsa-mir-520h
;
hsa-mir-520g-3p
;
hsa-mir-6504-3p
;
hsa-mir-512-3p
;
hsa-mir-520e
;
hsa-mir-520d-3p
;
hsa-mir-520c-3p
;
hsa-mir-520b
;
hsa-mir-520a-3p
;
hsa-mir-373-3p
;
hsa-mir-372-3p
;
hsa-mir-302e
;
hsa-mir-302d-3p
;
hsa-mir-302c-3p
;
hsa-mir-302b-3p
;
hsa-mir-302a-3p
;
hsa-mir-93-5p
;
hsa-mir-526b-3p
;
hsa-mir-519d-3p
;
hsa-mir-20b-5p
;
hsa-mir-20a-5p
;
hsa-mir-17-5p
;
hsa-mir-106b-5p
;
hsa-mir-106a-5p
;
hsa-mir-1295a
;
hsa-mir-145-5p
;
hsa-mir-15a-3p
;
hsa-mir-1825
;
hsa-mir-199a-5p
;
hsa-mir-199b-5p
;
hsa-mir-4717-5p
;
hsa-mir-5195-3p
;
hsa-mir-548p
;
hsa-mir-5704
Nearest miRNA
hsa-mir-12136/Upstream/3042847; hsa-mir-101-1/Downstream/1237079;
Nearest TSS
ENST00000473358/Upstream/4255;
ENST00000483899/Downstream/8532;
Nearest CpG islands
None/Target,
chr1-CpG: 111/Upstream/4009
,
chr1-CpG: 91/Downstream/62213
Upstream sequence
attggggaaaattggaagcagttgtaagtaacatgccatgaacatccatatacttaagactgtagcctccatttctgttttctcaggatgaattcttaga
Downstream sequence
tatgcagttgccagatcaaaagcataaagtctttgaaaggtttttagtaaatTTAGATTATACAAGTCAAATTGGCTATTACATGGGGTAGTATATGTAG
Reference
Sherrill-Mix, S., et al. HIV latency and integration site placement in five cell-based models.2013, Retrovirology 10: 90.
Sample Information
×
Sample name
Active CD4+
Sample type
Cell line
Gender
Female
CpG Island Information
×
Download
Curate